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    In recent years, the incidence of coronary artery 
disease (CAD) and cerebral vascular accident (CVA) 
has increased across the world. It has become a major 
problem of atherosclerotic cardiovascular disease 
(ASCVD). Consequently, the policy of refraining from 
lipids has been known from many years as 
recommended nutrition and diet therapy. The 
rationale for this lies in the study, which Keys et al. 
conducted formerly a Seven Countries study [1]. In 
addition, some reports showed that CAD is associated 
with a high-saturation diet (saturated fatty acid intake 
of 20% or more of total energy) in some countries 
with high frequency [2]. 
 
    After that, however, different results were reported. 
In other words, there was no significant correlation 
between saturated fatty acid (SFA) and lipid 
intake/mortality / cardiovascular disease incidence, or 
the risk was lower with converse correlation [3]. Then, 
reports showing various relationships continued, and 
it was in a state of controversy [4]. Under such 
circumstances, the Prospective Urban Rural 
Epidemiology (PURE) study was conducted. This is a 
prospective cohort study conducted jointly in 18 
countries on five continents. And the main results were 
reported in 2017 [5]. A new finding was that fat intake 
was negatively correlated with total mortality, with 
higher fat intake resulting in lower total mortality. 
Furthermore, carbohydrate intake was positively 
correlated with total mortality, with higher 
carbohydrate intake resulting in higher total mortality. 
The evidence of the effectiveness of a low carbohydrate  
Abstract 
    Whether saturated fatty acid (SFA) has a clinical influence on atherosclerotic cardiovascular disease 
(ASCVD) or not has been disputed. Prospective Urban Rural Epidemiology (PURE) study was recently 
summarized from 21 countries with about 150 thousand data. Dairy intake was negatively correlated with the 
prevalence of metabolic syndrome and the incidence of diabetes and hypertension. To increase the intake 
of dairy products would be easy and inexpensive to continue for treatment. P olyunsaturated fatty 
acid (PUFA) and monounsaturated fatty acid (MUFA) may reduce atherosclerotic diseases with beneficial 
effects. Clinical evidence of SFA will be hopefully accumulated for practice and research in the future. 
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diet (LCD) had a great impact on the world. 
 
    What is going on in actual clinical practice? The 
Guidelines of the American Heart Association (AHA) in 
2019 recommend replacing SFA with unsaturated fatty 
acids [6]. However, the evidence level is B-NR. As per 
the criteria, A is the best, B is the second-best, and B-
NR is lower than BR [moderate quality randomized 
controlled trial (RCT).  
 
    Currently, the latest PURE study report was 
reported [7]. The previous paper of PURE (2017) was 
from 18-country with 7.4 years, and the current paper 
(2020) was from 21 countries with 153,320 data. 
Actually, 147,812 data were analyzed with 9.1 years on 
average. Dairy intake was negatively correlated with 
the prevalence of metabolic syndrome and the 
incidence of diabetes and hypertension. The 
relationship was found in whole-fat milk and butter, 
but less in low-fat milk. This report will be important 
in considering the ideal intake of SFA and the ideal 
dietary recommendations. 
 
    As dairy intake becomes higher, blood pressure, 
abdominal circumference, BMI, TG, and blood glucose 
levels become lower [7]. The prevalence of metabolic 
syndrome was significantly lower in the population 
with higher dairy intake. The odds ratio (OR) for total 
dairy intake serving 0, 1, 2, 2< per day was 1.00, 0.91, 
0.87, 0.76 (P <0.0001), respectively. The OR for 
whole-fat dairy was 1.00, 0.90, 0.79, 0.72 (P <0.0001), 
and the OR for butter with much amount of SFA was 
1.00, 0.84, 0.72, 0.71 (P <0.0001), respectively. These 
relationships were the same when analyzed separately 
for the amount of salt intake, the amount of potassium 
intake, and the amount of fruit and vegetable intake. 
These data are from PURE (2020) [7], and the related 
data of PURE (2017) showed that the incidence of CVA 
was 1, 1.01, 0.78, 0.66 (p=0.0003) [8]. 
 
    According to a previous PURE study, a negative 
correlation was found between dairy intake values and 
cardiovascular event incidence and overall mortality 
[9]. The relationship was strong in whole-fat milk in 
this study as well [7]. From the above, increasing the 
intake of dairy products is easy and inexpensive to 
continue. This  method  enables  effective  way  against 
 
 
metabolic syndrome, hypertension, and diabetes. As a 
result, it can lead to reduced cardiovascular events and 
mortality. Consequently, dairy products are not 
necessarily low-fat milk. 
 
    Previous RCTs examined how much ratio SFA would 
be reduced for the efficacy. It assessed the effect of 
reducing SFA intake and replacing it with 
carbohydrate, polyunsaturated fatty acid (PUFA), or 
monounsaturated fatty acid (MUFA), and/or protein 
on mortality and cardiovascular morbidity [10]. As a 
result, no clear figures can be obtained, but it seems 
that about 10% is the cutoff level. When the control 
group takes 10% and >10 % of SFA and the target 
group takes <10% of SFA, the intervention group 
suggests a decrease in cardiovascular events. It was 
9% in 2015, but it changed to 10% in the 2020 update 
report. 
 
    In the previous meta-analysis of cohort studies, it 
was expected that replacing SFA intake with PUFA 
would reduce CAD [11]. A recent National Health and 
Nutrition Examination Survey (NHANES) and meta-
analysis reported that total fat intake reduced 
mortality, while saturated fat intake increased 
mortality and that negative associations were found 
between stroke mortality and MUFA (HR 0.80) and 
PUFA (HR 0.84) intakes [12]. Concerning MUFA and 
PUFA, a Mediterranean diet includes them much 
amount and can reduce CVD in older people [13]. Their 
beneficial effects are found for extending lifespan and 
lipids profile [14], which may be involved in the 
mechanism of senescence-accelerated mouse-prone 8 
(SAMP8) and senescence-accelerated mouse resistant 1 
(SAMR1) [15].  
 
    Some reports revealed that replacing SFA with 
PUFA in RCTs reduces heart disease [16], and 
conversely, others showed that heart disease might 
increase [17,18]. Under the above circumstances, 
various studies such as RCTs and cohort studies have 
been conducted on the relationship between lipids and 
arteriosclerosis. However, consistent results have not 
been obtained. The causes may be i) diets are different 
every day and do not always contain constant 
ingredients, ii) diversity emerges in many countries 
with a large number of subjects, iii) there are
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inhomogeneous conditions and complications for 
several diseases of arteriosclerosis. 
 
    As a result, it is difficult to conclude that lipids 
should be restricted or SFA should be restricted. On 
the other hand, the author and collaborators have been 
providing medical care for diabetes, dyslipidemia, 
hypertension, and obesity for many years [19,20]. 
Furthermore, we have developed and enlightened the 
importance of a low carbohydrate diet (LCD) [21,22]. 
Previous research on lipids and ASCVD suggest that 
lipid restriction and energy restriction may lead to the 
negative direction, and conversely, LCD may lead to 
the positive direction for better management of 
ASCVD.  
 
    In summary, the current PURE study would become 
a meaningful report for the problem concerning lipids 
and metabolic syndrome. It may become a milestone 
about the appropriate diet for ASCVD diseases. Further 
research will be expected to accumulate significant 
data in the future. 
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